<DOC>
	<DOCNO>NCT00653172</DOCNO>
	<brief_summary>The purpose study compare efficacy , safety tolerance 2 different dose level oral NXL103 oral comparator treatment community acquire pneumonia adult</brief_summary>
	<brief_title>Comparative Study NXL103 Versus Comparator Adults With Community Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Streptogramin A</mesh_term>
	<criteria>Community acquire pneumonia severe CAP respiratory infection attribute source community acquire bacterial infection concomitant pulmonary disease history hypersensitivity study medication , macrolide beta lactam antibiotic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>CAP</keyword>
	<keyword>community acquire pneumonia</keyword>
</DOC>